Back HIV Policy & Advocacy

HIV Policy & Advocacy

Definition of Brave: Long Term Survivors Reunite at Town Hall Forum in San Francisco

The AIDS generation has come alive again. It was apparent in the collective wisdom of over 175 AIDS survivors and their supporters and loved ones gathered in the packed Rainbow Room at San Francisco’s LGBT Center on September 16.

Over the past several months, Tez Anderson and several local AIDS activists had been organizing the town hall forum, entitled "Definition of Brave." The forum was organized to begin to understand and address a series of problems including severe depression, isolation, and suicide -- all related to living through and surviving AIDS for 20 years or more. 

alt

Read more:

HIV Infections Fall by 33% Overall, 52% Among Children Since 2001, Says UNAIDS

HIV incidence, or new infections, have decreased by more than one-third overall and by half among children over the past decade, and widening access to antiretroviral therapy has helped push AIDS-related mortality down by 30% since its peak in 2005, according to a new report released today by UNAIDS. The report also looks at HIV/AIDS funding, legal restrictions on people with HIV, and other challenges to ending the epidemic.

alt

Read more:

ADAP Crisis Task Force and ViiV Agree on Discounted Price for Dolutegravir

The ADAP Crisis Task Force (ACTF) announced this week that it has negotiated an agreement with ViiV Healthcare to provide the newly approved integrase inhibitor dolutegravir (Tivicay) to AIDS Drug Assistance Program (ADAP) recipients for less than the wholesale cost.

alt

Read more:

U.S. Conference on AIDS Focuses on Epidemic in the South

The annual U.S. Conference on AIDS (USCA 2013), sponsored by the National Minority AIDS Council, took place this week in New Orleans, highlighting the burgeoning HIV epidemic in the southern states. Other themes included the Affordable Care Act, HIV prevention, aging, and fighting HIV stigma and criminalization.alt

Read more:

IAS 2013: Middle-income Countries Outside Africa Pay Four Times More for Antiretroviral Drugs

Middle-income countries outside Africa are paying, on average, 4 times more for antiretrovirals than African countries with similar gross national incomes (GNI), according to a study presented recently at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur.

alt

[Produced in collaboration with Aidsmap.com]

Read more: